P. F. Halloran, Immunosuppressive Drugs for Kidney Transplantation. New England, J. Med, vol.351, pp.2715-2729, 2004.
DOI : 10.1056/nejmra033540

D. C. Borie, J. J. O'shea, and P. S. Changelian, JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants, Trends Mol. Med, vol.10, issue.11, pp.532-541, 2004.

J. Dantal and E. Pohanka, Malignancies in renal transplantation: an unmet medical need, Nephrol. Dial. Transplant, vol.22, pp.4-10, 2007.

A. V. Villarino, Y. Kanno, and J. J. O'shea, Mechanisms and consequences of Jak-STAT signaling in the immune system, Nat. Immunol, vol.18, issue.4, pp.374-384, 2017.

R. Morris, N. J. Kershaw, and J. J. Babon, The molecular details of cytokine signaling via the JAK/STAT pathway, Protein Sci, vol.27, issue.12, pp.1984-2009, 2018.

A. C. Pfeifer and J. Timmer, UrsulaKlingmu ller, Systems biology of JAK/STAT signalling, Essays Biochem, vol.45, pp.109-120, 2008.

E. Bousoik and . Hamidreza-montazeri-aliabadi, Do We Know Jack" About JAK? A Closer Look at JAK/STAT Signaling Pathway, Front, Oncol, vol.8, 2018.

K. Ghoreschi, A. Laurence, and J. J. O'shea, Janus kinases in immune cell signaling, Immunol. Rev, vol.228, issue.1, pp.273-287, 2009.

L. A. Winston and T. Hunter, JAK2, Ras, and raf are required for activation of extracellular signal-regulated Kinase/Mitogen-activated protein kinase by growth hormone, J. Biol. Chem, vol.270, issue.52, pp.30837-30840, 1995.

D. Bouscary, Y. Fre-deric-pene, O. Claessens, . Muller, M. Stany-chre-tien et al., Critical role for PI 3-kinase in the control of erythropoietininduced erythroid progenitor proliferation, Blood, vol.101, issue.9, pp.3436-3443, 2003.

R. Roskoski, Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes, Pharmacol. Res, vol.103, pp.26-48, 2016.

O. Silvennoinen, J. N. Ihle, J. Schlessinger, and D. E. Levy, Interferoninduced nuclear signalling by Jak protein tyrosine kinases, Nature, vol.366, issue.6455, pp.583-585, 1993.
DOI : 10.1038/366583a0

P. C. Heinrich, I. Behrmann, G. Muller-newen, F. Schaper, and L. Graeve, Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway, Biochem. J, vol.334, issue.2, pp.297-314, 1998.

J. A. Johnston, C. M. Bacon, M. C. Riedy, and J. J. O'shea, Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency, J. Leukoc. Biol, vol.60, issue.4, pp.441-452, 1996.
DOI : 10.1002/jlb.60.4.441

H. P. Ruud, D. R. Wilbers, L. B. Van-raaij, J. Westerhof, G. Bakker et al., Arjen Schots, Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10r2 chain, PLoS One, vol.12, issue.10, 2017.

K. Igarashi, G. Garotta, L. Ozmen, A. Ziemiecki, A. F. Wilks et al., Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor, J. Biol. Chem, vol.269, pp.14333-14336, 1994.

M. F. Brizzi, M. G. Aronica, A. Rosso, G. P. Bagnara, Y. Yarden et al., Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93, STAT1 p91, and STAT3 p92 in Polymorphonuclear Leukocytes, J. Biol. Chem, vol.271, issue.7, pp.3562-3567, 1996.

A. Bruce, F. W. Witthuhn, O. Quelle, T. Silvennoinen, B. Yi et al., JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin, Cell, vol.74, issue.2, pp.227-236, 1993.

C. M. Bacon, D. W. Mcvicar, J. R. Ortaldo, R. C. Rees, J. J. Shea et al., IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12, J. Exp. Med, vol.12, issue.1, pp.399-404, 1995.

J. A. Johnston, M. Kawamura, R. A. Kirken, Y. Q. Chen, T. B. Blake et al., Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2, Nature, vol.370, issue.6485, pp.151-153, 1994.

N. Stahl, T. G. Boulton, T. Farruggella, N. Y. Ip, S. Davis et al., Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components, Science, vol.263, issue.5143, pp.92-95, 1994.
DOI : 10.1126/science.8272873

C. Abramovich, L. M. Shulman, E. Ratovitski, S. Harroch, M. Tovey et al., Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta, EMBO J, vol.13, pp.5871-5877, 1994.

D. M. Floss, J. Tobiasklocker, L. Schroder, S. Lamertz, B. Mrotzek et al., Defining the functional binding sites of interleukin 12 receptor b1 and interleukin 23 receptor to Janus kinases, Mol. Biol. Cell, vol.27, issue.14, pp.2301-2316, 2016.

, Various JAK inhibitor clinical trials (US). avaliable at, 2018.

D. Gladman, W. Rigby, F. Valderilio, F. Azevedo, R. Behrens et al., Tofacitinib for Psoriatic Arthritis in Patients With an Inadequate Response to TNF Inhibitors, 2017.

C. Mark, J. Genovese, O. Kremer, C. Zamani, M. Ludivico et al., Baricitinib in Patients With Refractory Rheumatoid Arthritis, 2016.

K. L. Winthrop, The emerging safety profile of JAK inhibitors in rheumatic disease, Nat. Rev. Rheumatol, vol.13, issue.4, pp.234-243, 2017.

E. Parganas, D. Wang, D. Stravopodis, D. J. Topham, J. Marine et al., Cytokine and Growth Factor Reviews, vol.47, pp.62-73, 2019.

R. Colamonici, J. M. Deursen, G. Grosveld, and J. N. Ihle, Jak2 is essential for signaling through a variety of cytokine receptors, Cell, vol.93, issue.3, pp.385-395, 1998.

P. Macchi, A. Villa, S. Giliani, M. G. Sacco, A. Frattini et al., Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID), Nature, vol.377, issue.6544, pp.65-68, 1995.

J. Scott, M. A. Rodig, J. M. Meraz, P. A. White, J. K. Lampe et al., Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the jaks in cytokine-induced biologic responses, Cell, vol.93, issue.3, pp.373-383, 1998.

S. Y. Shi, W. Zhang, C. T. Luk, T. Sivasubramaniyam, J. J. Brunt et al., JAK2 promotes brown adipose tissue function and is required for diet-and cold-induced thermogenesis in mice, Diabetologia, vol.59, issue.1, pp.187-196, 2016.

M. Chikugo, M. Sebe, R. Tsutsumi, M. Iuchi, J. Kishi et al., Effect of Janus kinase inhibition by tofacitinib on body composition and glucose metabolism, J. Med. Investig, vol.65, p.5, 2018.

P. Gallipoli, A. Cook, S. Rhodes, L. Hopcroft, H. Wheadon et al., JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo, Blood, vol.124, issue.9, pp.1492-1501, 2014.

D. Zacharaki, R. Ghazanfari, H. Li, C. Hooi, S. Lim et al., Effects of JAK1/2 inhibition on bone marrow stromal cells of myeloproliferative neoplasm (MPN) patients and healthy individuals, Eur. J. Haematol, vol.101, issue.1, pp.57-67, 2018.

S. C. Meyer, M. D. Keller, B. A. Woods, L. M. Lafave, L. Bastian et al., Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesis, Blood, vol.124, issue.14, pp.2280-2284, 2014.

C. A. Janeway, P. Travers, M. Walport, M. J. Shlomchik, and C. A. Janeway, Immunobiology, 2001.

C. Munz, Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells, Blood, vol.105, issue.1, pp.266-273, 2005.

A. Kezic, N. Stajic, and F. Thaiss, Innate immune response in kidney Ischemia/Reperfusion injury: potential target for therapy, J. Immunol. Res, p.2017, 2017.

Q. Zhuang, Q. Liu, S. J. Divito, Q. Zeng, K. M. Yatim et al., Graft-infiltrating host dendritic cells play a key role in organ transplant rejection, Nat. Commun, vol.7, p.12623, 2016.
DOI : 10.1038/ncomms12623

URL : https://www.nature.com/articles/ncomms12623.pdf

Y. Huang, P. Johnston, B. Zhang, A. Zakari, T. Chowdhry et al., Kidney-derived stromal cells modulate dendritic and t cell responses, J. Am. Soc. Nephrol, vol.20, issue.4, pp.831-841, 2009.
DOI : 10.1681/asn.2008030310

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663835/pdf

A. H. Wagner, M. Conzelmann, F. Fitzer, T. Giese, K. Gülow et al., JAK1/STAT3 activation directly inhibits IL-12 production in dendritic cells by preventing CDK9/P-TEFb recruitment to the p35 promoter, Biochem. Pharmacol, vol.96, issue.1, pp.52-64, 2015.

P. C. Patrick, P. E. Boor, P. S. De-ruiter, E. Asmawidjaja, . Lubberts et al., JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa, Transl. Res, vol.188, pp.67-79, 2017.

D. Sarhan, M. Palma, Y. Mao, L. Adamson, R. Kiessling et al., Dendritic cell regulation of NK-cell responses involves lymphotoxin-a, IL-12, and TGF-b, Eur. J. Immunol, vol.45, issue.6, pp.1783-1793, 2015.

N. Degauque, S. Brouard, and J. Soulillou, Cross-reactivity of TCR repertoire: current concepts, challenges, and implication for allotransplantation, Front. Immunol, vol.7, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02153397

C. A. Su, S. Iida, T. Abe, and R. L. Fairchild, Endogenous memory CD8 t cells directly mediate cardiac allograft rejection: endogenous memory CD8 t cell allograft rejection, Am. J. Transplant, vol.14, issue.3, pp.568-579, 2014.
DOI : 10.1111/ajt.12605

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.12605

M. Prerak, K. L. Trivedi, N. A. Graham, M. R. Scott, S. Jenkins et al., Repurposed JAK1/JAK2 inhibitor reverses established autoimmune insulitis in NOD mice, Diabetes, vol.66, issue.6, pp.1650-1660, 2017.

E. Van-gurp, W. Weimar, R. Gaston, D. Brennan, R. Mendez et al., Phase 1 doseescalation study of CP-690 550 in stable renal allograft recipients: preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics, Am. J. Transplant, vol.8, issue.8, pp.1711-1718, 2008.

R. Vafadari, M. E. Quaedackers, M. M. Kho, W. M. Mol, G. Chan et al., Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients, Transplantation, vol.94, issue.5, p.465, 2012.

B. Sun and Y. Zhang, Overview of orchestration of CD4+ T cell subsets in immune responses, Adv. Exp. Med. Biol, vol.841, pp.1-13, 2014.

K. Ghoreschi, M. I. Jesson, X. Li, J. L. Lee, S. Ghosh et al., Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550), Journal of Immunology, vol.186, issue.7, pp.4234-4243, 1950.

H. Kishi, S. Inui, A. Muraguchi, T. Hirano, Y. Yamamura et al., Induction of IgG secretion in a human B cell clone with recombinant IL 2, J. Immunol, vol.134, issue.5, pp.3104-3107, 1985.

O. Boyman, A. G. Kolios, and M. E. Raeber, Modulation of T Cell Responses by IL-2 and IL-2 Complexes, p.4, 2015.

A. Senik, S. Stefanos, J. P. Kolb, M. Lucero, and E. Falcoff, Enhancement of mouse natural killer cell activity by type II interferon, Ann. Immunol. (Paris), vol.131, issue.3, pp.349-361, 1980.

C. F. Nathan, H. W. Murray, M. E. Wiebe, Y. Berish, and . Rubin, Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity, J. Exp. Med, vol.158, issue.3, pp.670-689, 1983.

N. M. Orr-el-weizman, I. Adams, C. Schuster, Y. Krishna, C. Pritykin et al., ILC1 confer early host protection at initial sites of viral infection, Cell, vol.171, issue.4, pp.795-808, 2017.

W. Jungraithmayr, L. Ji, L. Yang, W. Weder, S. Korom et al., Increased Tbet to GATA-3 ratio during acute allograft rejection in the rat lung, Transplant. Proc, vol.41, issue.10, pp.4316-4320, 2009.

X. Zuo, Y. Matsumura, J. Prehn, R. Saito, A. Marchevesky et al., Cytokine gene expression in rejecting and tolerant rat lung allograft models: analysis by RT-PCR, Transpl. Immunol, vol.3, issue.2, pp.151-161, 1995.

Z. Liu, H. Fan, and S. Jiang, CD4+ T-cell subsets in transplantation, Immunol. Rev, vol.252, issue.1, pp.183-191, 2013.

K. Maeshima, K. Yamaoka, S. Kubo, K. Nakano, S. Iwata et al., The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-g and interleukin-17 production by human CD4+ T cells, Arthritis Rheum, vol.64, issue.6, 2012.

S. Gertel, H. Mahagna, G. Karmon, A. Watad, and H. Amital, Tofacitinib attenuates arthritis manifestations and reduces the pathogenic CD4 T cells in adjuvant arthritis rats, Clin. Immunol, vol.184, pp.77-81, 2017.

J. S. Fridman, P. A. Scherle, R. Collins, T. C. Burn, Y. Li et al., Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050, J. Immunol, vol.184, issue.9, pp.5298-5307, 2010.

J. Telliez, M. E. Dowty, L. Wang, J. Jussif, T. Lin et al., Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition, vol.11, pp.3442-3451, 2016.

T. Deuse, J. B. Velotta, G. Hoyt, J. A. Govaert, V. Taylor et al., Novel immunosuppression: R348, a JAK3-and syk-inhibitor attenuates acute cardiac allograft rejection, Transplantation, vol.85, issue.6, pp.885-892, 2008.
DOI : 10.1097/tp.0b013e318166acc4

M. Kubo, Innate and adaptive type 2 immunity in lung allergic inflammation, Immunol. Rev, vol.278, issue.1, pp.162-172, 2017.
DOI : 10.1111/imr.12557

T. Kouro, Y. Kikuchi, H. Kanazawa, K. Hirokawa, N. Harada et al., Critical proline residues of the cytoplasmic domain of the IL-5 receptor alpha chain and its function in IL-5-mediated activation of JAK kinase and STAT5, Int. Immunol, vol.8, issue.2, pp.237-245, 1996.

Y. Chiba, K. Goto, and M. Misawa, Interleukin-13-induced activation of signal transducer and activator of transcription 6 is mediated by an activation of Janus kinase 1 in cultured human bronchial smooth muscle cells, Pharmacological reports: PR, vol.64, issue.2, pp.454-458, 2012.

M. M. , R. Josien, M. Manghetti, A. Amedei, M. C. Marco-de-carli et al., Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts, Kidney Int, vol.51, issue.6, pp.1876-1884, 1997.

A. Nocera, A. Tagliamacco, R. Palma, F. D. Galdo, A. Ferrante et al., Cytokine mRNA expression in chronically rejected human renal allografts, Clin. Transplant, vol.18, issue.5, pp.564-570, 2004.
DOI : 10.1111/j.1399-0012.2004.00227.x

K. Ghoreschi, M. I. Jesson, X. Li, J. L. Lee, S. Ghosh et al., Cytokine and Growth Factor Reviews, vol.47, pp.62-73, 2019.

N. Kishore and J. J. O'shea, Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550), J. immune, vol.186, issue.7, pp.4234-4243, 1950.

C. Haan, C. Rolvering, F. Raulf, M. Kapp, P. Druckes et al., Jak1 Has a Dominant Role over Jak3 in Signal Transduction through gc-Containing Cytokine Receptors, Chem. Biol, vol.18, issue.3, pp.314-323, 2011.

E. M. Eisenstein and C. B. Williams, The Treg/Th17 cell balance: a new paradigm for autoimmunity, Pediatr. Res, vol.65, issue.5, 2009.

O. Palomares, M. Martín-fontecha, R. Lauener, C. Traidl-hoffmann, O. Cavkaytar et al., Akdis, Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-b, Genes Immun, vol.15, issue.8, pp.511-520, 2014.

S. Fu, N. Zhang, A. C. Yopp, D. Chen, M. Mao et al., TGF-b induces Foxp3 + T-Regulatory cells from CD4 + CD25 -precursors, Am. J. Transplant, vol.4, issue.10, pp.1614-1627, 2004.
DOI : 10.1111/j.1600-6143.2004.00566.x

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-6143.2004.00566.x

A. Chaudhry, D. Rudra, P. Treuting, R. M. Samstein, Y. Liang et al., CD4+ regulatory T cells control Th17 responses in a Stat3-dependent manner, vol.326, pp.986-991, 2009.

C. Thomas, . Mangodt, A. Mikha?l, S. Van-herck, J. Nullens et al., The role of Th17 and Treg responses in the pathogenesis of RSV infection, Pediatr. Res, vol.78, issue.5, pp.483-491, 2015.

B. C. Betts, O. Abdel-wahab, S. A. Curran, E. T. St-angelo, P. Koppikar et al., Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell--stimulated T cells yet preserves immunity to recall antigen, Blood, vol.118, pp.5330-5339, 2011.
DOI : 10.1182/blood-2011-06-363408

URL : http://www.bloodjournal.org/content/118/19/5330.full.pdf

J. Park, J. Lee, M. Lim, E. Kim, S. Kim et al., JAK2-STAT3 blockade by AG490 suppresses autoimmune arthritis in mice via reciprocal regulation of regulatory t cells and Th17 cells, J. Immunol, vol.192, issue.9, pp.4417-4424, 2014.

B. C. Betts, D. Bastian, H. Nguyen, J. L. Heinrichs, W. Yongxia et al., Yu Xue-Zhong, Targeting JAK2 by Gene Knockout or pacritinib treatment reduces gvhd and xenograft rejection by promoting induced treg differentiation, Blood, vol.126, issue.23, pp.1874-1874, 2015.

M. Cetkovic-cvrlje, M. Olson, and K. Ghate, Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-b by CD4+ T cells, Cell. Mol. Immunol, vol.9, issue.4, pp.350-360, 2012.

K. Ghoreschi, A. Laurence, X. Yang, C. Tato, M. J. Mcgeachy et al., Generation of pathogenic Th17 cells in the absence of TGF-b signaling, Nature, vol.467, pp.967-971, 2010.

M. Laan, Z. H. Cui, H. Hoshino, J. Lötvall, M. Sjöstrand et al., Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways, J. Immun, vol.162, issue.4, pp.2347-2352, 1950.

M. Ishizaki, R. Muromoto, T. Akimoto, Y. Sekine, S. Kon et al., Tyk2 is a therapeutic target for psoriasis-like skin inflammation, Int. Immunol, vol.26, issue.5, pp.257-267, 2014.
DOI : 10.1093/intimm/dxt062

URL : https://academic.oup.com/intimm/article-pdf/26/5/257/17415009/dxt062.pdf

T. Duhen, R. Geiger, D. Jarrossay, A. Lanzavecchia, and F. Sallusto, Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells, Nat. Immunol, vol.10, issue.8, pp.857-863, 2009.

T. Wang, Z. Zhang, H. Xing, L. Wang, G. Zhang et al., Elevated Th22 cells and related cytokines in patients with epithelial ovarian cancer, Medicine, vol.96, issue.43, 2017.

P. J. Mclaughlin, A. Aikawa, H. M. Davies, R. G. Ward, A. Bakran et al., Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients, Transplantation, vol.51, issue.6, pp.1225-1229, 1991.

S. Heidenreich, D. Lang, M. Tepel, and K. H. Rahn, Monocyte activation for enhanced tumour necrosis factor-alpha and interleukin 6 production during chronic renal allograft rejection, Transpl. Immunol, vol.2, issue.1, pp.35-40, 1994.

P. Kapessidou, L. Poulin, L. Dumoutier, M. Goldman, J. Renauld et al., Interleukin-22 deficiency accelerates the rejection of full major histocompatibility complex-disparate heart allografts, Transplant. Proc, vol.40, issue.5, pp.1593-1597, 2008.

H. Chang, H. Hanawa, H. Liu, T. Yoshida, M. Hayashi et al., Hydrodynamic-based delivery of an Interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats, J. Immunol, vol.177, issue.6, pp.3635-3643, 2006.

I. Gomez, N. Foudi, D. Longrois, and X. Norel, The role of prostaglandin E2 in human vascular inflammation, Prostaglandins Leukot. Essent. Fatty Acids, vol.89, issue.2-3, pp.55-63, 2013.

Y. Chao-chao-qin, Y. Liu, Y. Hu, Z. Yang, and . Chen, Macrophage inflammatory protein-2 as mediator of inflammation in acute liver injury, World J. Gastroenterol, vol.23, issue.17, pp.3043-3052, 2017.

L. Satish, S. Deshmane, S. Kremlev, B. E. Amini, and . Sawaya, Monocyte chemoattractant Protein-1 (MCP-1): an overview, J. Interferon Cytokine Res, vol.29, issue.6, pp.313-326, 2009.

F. Shibata, The role of rat cytokine-induced neutrophil chemoattractants (CINCs) in inflammation

, Yakugaku Zasshi, J. Pharma. Soc. Japan, vol.122, issue.4, pp.263-268, 2002.

R. J. Noelle and E. C. Nowak, Cellular sources and immune functions of interleukin-9, Nat. Rev. Immunol, vol.10, issue.10, pp.683-687, 2010.

K. A. Kortekaas, K. Dorottya, . De-vries, E. J. Marlies, E. Reinders et al., Interleukin-9 release from human kidney grafts and its potential protective role in renal ischemia/ reperfusion injury, Inflamm. Res, vol.62, issue.1, pp.53-59, 2013.
DOI : 10.1007/s00011-012-0550-7

M. Gajendra, S. Jogdand, and . Mohanty, Satish Devadas, Regulators of tfh cell differentiation, Front. Immunol, vol.7, 2016.

N. Schmitt, R. Morita, L. Bourdery, S. E. Bentebibel, S. M. Zurawski et al., Human dendritic cells induce the differentiation of Interleukin-21-producing t follicular helper-like cells through Interleukin-12, Immunity, vol.31, issue.1, pp.158-169, 2009.

S. K. Lee, D. G. Silva, J. L. Martin, A. Pratama, X. Hu et al., Interferon-g excess leads to pathogenic accumulation of follicular helper t cells and germinal centers, Immunity, vol.37, issue.5, pp.880-892, 2012.

.. C. Christopherd, K. M. Allen, C. Ansel, R. Low, H. Lesley et al., Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5, Nat. Immunol, vol.5, issue.9, pp.943-952, 2004.

A. Kolenbrander, B. Grewe, D. Nemazee, K. Überla, and V. Temchura, Generation of T follicular helper cells in vitro: requirement for B-cell receptor cross-linking and cognate B-and T-cell interaction, Immunology, vol.153, issue.2, pp.214-224, 2018.

. Kitty-de-leur, J. M. Frank, M. Dor, . Dieterich, J. W. Luc et al., IL-21 receptor antagonist inhibits differentiation of B cells toward plasmablasts upon alloantigen stimulation, Front. Immunol, vol.8, 2017.

T. Defrance, B. Vanbervliet, J. Pène, and J. Banchereau, Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM, J. Immunol, vol.141, issue.6, 1988.
DOI : 10.1084/jem.165.6.1459

URL : http://jem.rupress.org/content/165/6/1459.full.pdf

G. De-graav, M. Dieterich, D. A. Hesselink, K. Boer, M. C. Clahsen-van-groningen et al., Follicular T helper cells and humoral reactivity in kidney transplant patients, Clin. Exp. Immunol, vol.180, issue.2, pp.329-340, 2015.

T. M. Conlon, K. Saeb-parsy, J. L. Cole, R. Motallebzadeh, M. S. Qureshi et al., Germinal centre alloantibody responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells, J. Immunol, vol.188, issue.6, pp.2643-2652, 2012.
DOI : 10.4049/jimmunol.1102830

URL : http://www.jimmunol.org/content/188/6/2643.full.pdf

J. Marino, J. T. Paster, A. Trowell, L. Maxwell, K. H. Briggs et al., B cell depletion with an Anti-CD20 antibody enhances alloreactive memory t cell responses after transplantation, Am. J. Transplant, vol.16, issue.2, pp.672-678, 2016.
DOI : 10.1111/ajt.13483

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.13483

E. J. Kim, J. Kwun, A. C. Gibby, J. J. Hong, A. B. Farris et al., Costimulation blockade alters germinal center responses and prevents antibodymediated rejection, Am. J. Transplant, vol.14, issue.1, pp.59-69, 2014.
DOI : 10.1111/ajt.12526

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.12526

B. Miles and E. Connick, Control of the germinal center by follicular regulatory t cells during infection, vol.9, 2018.

C. S. Ma, D. T. Avery, A. Chan, M. Batten, J. Bustamante et al., Functional STAT3 deficiency compromises the generation of human T follicular helper cells, Blood, vol.119, issue.17, pp.3997-4008, 2012.

L. Li and Z. Li, Effects of tofacitinib on Tfr/Tfh balance and expression of CXCL13 and TGF-b1 in experimental autoimmune encephalomyelitis rats, Cns Neurol. Disord. -Drug Targets, 2018.

J. Punnonen, G. Aversa, and J. E. De-vries, Human pre-B cells differentiate into Igsecreting plasma cells in the presence of interleukin-4 and activated CD4+ T cells or their membranes, Blood, vol.82, issue.9, pp.2781-2789, 1993.

. M. Terry-ann, R. J. Milford, O. L. Su, I. Francis, . Baez et al., TSLP or IL-7 provide an IL-7ra signal that is critical for human B lymphopoiesis, Eur. J. Immunol, vol.46, issue.9, pp.2155-2161, 2016.

I. K. Mcniece, K. E. Langley, and K. M. Zsebo, The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL-7, J. Immun, vol.146, issue.11, pp.3785-3790, 1950.

S. M. Gough, L. Goldberg, M. Pineda, R. L. Walker, Y. J. Zhu et al., Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways, Blood Adv, vol.1, pp.1749-1759, 2017.

E. Mössner, P. Brünker, S. Moser, U. Püntener, C. Schmidt et al., Cytokine and Growth Factor Reviews, vol.47, pp.62-73, 2019.

S. Herter, R. Grau, C. Gerdes, A. Nopora, E. Puijenbroek et al., Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity, Blood, vol.115, pp.4393-4402, 2010.

W. Tucker, F. Lebien, and T. Thomas, B lymphocytes: how they develop and function, Blood, vol.112, issue.5, pp.1570-1580, 2008.

V. Seda and M. Mraz, B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells, Eur. J. Haematol, vol.94, issue.3, pp.193-205, 2015.

K. E. Gunn and J. W. Brewer, Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity, J. Immunol, vol.177, issue.6, pp.3791-3798, 2006.
DOI : 10.4049/jimmunol.177.6.3791

URL : http://www.jimmunol.org/content/177/6/3791.full.pdf

T. Defrance, M. Taillardet, and L. Genestier, T cell-independent B cell memory, Curr. Opin. Immunol, vol.23, issue.3, pp.330-336, 2011.

L. Stephen, P. D. Nutt, D. M. Hodgkin, L. M. Tarlinton, and . Corcoran, The generation of antibody-secreting plasma cells, Nat. Rev. Immunol, vol.15, issue.3, pp.160-171, 2015.

A. Koenig, C. Mariat, C. Mousson, K. J. Wood, and G. Rifle, Olivier Thaunat, B cells and antibodies in transplantation, Transplantation, vol.100, issue.7, p.1460, 2016.

O. Aubert, A. Loupy, L. Hidalgo, J. Huyen, S. Higgins et al., Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients, J. Am. Soc. Nephrol, vol.28, issue.6, pp.1912-1923, 2017.

J. Kwun, M. Manook, E. Page, C. Burghuber, J. Hong et al., Cross-talk between T and B cells in the Germinal Center following transplantation, Transplantation, vol.101, issue.4, pp.704-712, 2017.

Y. Zhang, L. Garcia-ibanez, and K. Toellner, Regulation of germinal center B-cell differentiation, vol.270, issue.1, pp.8-19, 2016.

M. C. Ochoa, L. Minute, I. Rodriguez, S. Garasa, E. Perez-ruiz et al., Antibodydependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells, Immunol. Cell Biol, vol.95, issue.4, pp.347-355, 2017.
DOI : 10.1038/icb.2017.6

C. Wehmeier, G. Hönger, H. Cun, P. Amico, P. Hirt-minkowski et al., Donor specificity but not broadness of sensitization is associated with antibody-mediated rejection and graft loss in renal allograft recipients, Am. J. Transplant, vol.17, issue.8, pp.2092-2102, 2017.

G. Martins and K. Calame, Regulation and functions of Blimp-1 in t and B lymphocytes, Annu. Rev. Immunol, vol.26, issue.1, pp.133-169, 2008.

B. , B. Ding, E. Bi, H. Chen, J. Yu et al., IL-21 and CD40l synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells, J. Immunol, vol.190, issue.4, pp.1827-1836, 2013.

E. K. Deenick, D. T. Avery, A. Chan, L. J. Berglund, M. L. Ives et al., Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells, J. Exp. Med, vol.210, issue.12, pp.2739-2753, 2013.

S. Kubo, S. Nakayamada, K. Sakata, Y. Kitanaga, X. Ma et al., Janus kinase inhibitor baricitinib modulates human innate and adaptive immune system, Front. Immunol, vol.9, 2018.

M. Rizzi, R. Lorenzetti, K. Fischer, J. Staniek, I. Janowska et al., Impact of tofacitinib treatment on human B-cells in vitro and in vivo, J. Autoimmun, vol.77, pp.55-66, 2017.

J. Stavnezer, E. J. Jeroen, C. E. Guikema, and . Schrader, Mechanism and regulation of class switch recombination, Annu. Rev. Immunol, vol.26, pp.261-292, 2008.

T. F. Tedder, B10 cells: a functionally defined regulatory B cell subset, J. Immunol, vol.194, issue.4, pp.1395-1401, 2015.

M. Chesneau, L. Michel, E. Dugast, A. Chenouard, D. Baron et al., Tolerant kidney transplant patients produce B cells with regulatory properties, J. Am. Soc. Nephrol, vol.26, issue.10, pp.2588-2598, 2015.
DOI : 10.1681/asn.2014040404

URL : https://hal.archives-ouvertes.fr/inserm-02148982

S. Fillatreau, C. H. Sweenie, M. J. Mcgeachy, D. Gray, and S. M. Anderton, B cells regulate autoimmunity by provision of IL-10, Nat. Immunol, vol.3, issue.10, pp.944-950, 2002.

A. Ray, L. Wang, and B. N. Dittel, IL-10-independent regulatory B-cell subsets and mechanisms of action, Int. Immunol, vol.27, issue.10, pp.531-536, 2015.

X. Zhou, Y. Su, X. Lao, Y. Liang, and G. Liao, CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells, Oral Oncol, vol.53, pp.27-35, 2016.

C. Brosseau, M. Durand, L. Colas, E. Durand, A. Foureau et al., Sophie Brouard, CD9+ regulatory B cells induce t cell apoptosis via IL-10 and are reduced in severe asthmatic patients, Front. Immunol, vol.9, 2018.

R. Wang, C. Yu, I. M. Dambuza, M. Rashid, M. Mahdi et al., Interleukin-35 induces regulatory B cells that suppress CNS autoimmune disease, Nat. Med, vol.20, issue.6, pp.633-641, 2014.
DOI : 10.1038/nm.3554

URL : http://europepmc.org/articles/pmc4048323?pdf=render

M. Kang, R. T. Lee, G. Stott, J. Zhao, W. Soohoo et al., TGF-b-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance: immunomodulation, Eur. J. Immunol, vol.44, issue.6, pp.1728-1736, 2014.

K. A. Newell, A. Asare, A. D. Kirk, T. D. Gisler, K. Bourcier et al., Seyfert-Margolis, Identification of a B cell signature associated with renal transplant tolerance in humans, J. Clin. Invest, vol.120, issue.6, pp.1836-1847, 2010.

M. Chesneau, A. Pallier, F. Braza, G. Lacombe, S. L. Gallou et al., Unique B cell differentiation profile in tolerant kidney transplant patients, Am. J. Transplant, vol.14, issue.1, pp.144-155, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00974748

C. Mauri, D. Gray, N. Mushtaq, and M. Londei, Prevention of arthritis by interleukin 10-producing B cells, J. Exp. Med, vol.197, issue.4, pp.489-501, 2003.

P. A. Blair, L. Y. Norenã, F. Flores-borja, D. J. Rawlings, D. A. Isenberg et al., CD19+CD24hi CD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients, Immunity, vol.32, issue.1, pp.129-140, 2010.
DOI : 10.1016/j.immuni.2009.11.009

URL : https://doi.org/10.1016/j.immuni.2009.11.009

, Autocrine stimulation of IL-10 is critical to the enrichment of IL-10-producing CD40hi CD5+ regulatory B cells in vitro and in vivo, BMB Rep, vol.48, issue.1, pp.54-59, 2015.

M. Karaghiosoff, H. Neubauer, C. Lassnig, P. Kovarik, H. Schindler et al., Mathias Mu ller, Partial impairment of cytokine responses in Tyk2-Deficient mice, Immunity, vol.13, issue.4, pp.549-560, 2000.

E. Montaldo, P. Vacca, C. Vitale, F. Moretta, F. Locatelli et al., Human innate lymphoid cells, Immunol. Lett, vol.179, pp.2-8, 2016.

E. Montaldo, G. D. Zotto, M. D. Chiesa, M. C. Mingari, A. Moretta et al., Human NK cell receptors/ markers: a tool to analyze NK cell development, subsets and function, Cytom. Part A, vol.83, issue.8, pp.702-713, 2013.
DOI : 10.1002/cyto.a.22302

O. Chijioke and C. Munz, Dendritic cell derived cytokines in human natural killer cell differentiation and activation, Front. Immunol, vol.4, 2013.
DOI : 10.3389/fimmu.2013.00365

URL : https://www.frontiersin.org/articles/10.3389/fimmu.2013.00365/pdf

A. Lindgren, V. Pavlovic, C. Flach, A. Sjöling, and S. Lundin, Interferon-gamma secretion is induced in IL-12 stimulated human NK cells by recognition of Helicobacter pylori or TLR2 ligands, Innate Immun, vol.17, issue.2, pp.191-203, 2011.

D. Cosner, M. Rooney, D. Samarpungavan, W. Li, S. Cohn et al., Ping Zhang, Natural killer cells are involved in both acute antibody mediated rejection and acute cellular rejection, Am. J. Clin. Pathol, vol.142, issue.1, pp.220-220, 2014.

B. Dreßke, X. Zhu, C. Herwartz, K. Brötzmann, and F. Fändrich, The time pattern of organ infiltration and distribution of natural killer cells and macrophages in the course of acute graft rejection after allogeneic heart transplantation in the rat, Transplant. Proc, vol.29, issue.3, pp.1715-1716, 1997.

N. Gao, T. Dang, and D. Yuan, IFN-g-Dependent and -Independent initiation of switch recombination by NK cells, J. Immunol, vol.167, issue.4, pp.2011-2018, 2001.

T. Resch, C. Fabritius, S. Ebner, P. Ritschl, and K. Kotsch, The role of natural killer cells in humoral rejection, Transplantation, vol.99, issue.7, pp.1335-1340, 2015.

A. F. Evelien, W. Van-gurp, M. Schoordijk-verschoor, S. S. Klepper, G. Korevaar et al., The effect of the JAK inhibitor CP-690,550 on peripheral immune parameters in stable kidney allograft patients, Transplantation, vol.87, issue.1, pp.79-86, 2009.

M. L. Robinette, M. Cella, J. B. Telliez, T. K. Ulland, A. D. Barrow et al., Jak3 deficiency blocks innate lymphoid cell development, Mucosal Immunol, vol.11, issue.1, pp.50-60, 2018.
DOI : 10.1038/mi.2017.38

URL : http://europepmc.org/articles/pmc5693788?pdf=render

B. Mcdonald, K. Pittman, G. B. Menezes, S. A. Hirota, I. Slaba et al., Intravascular danger signals guide neutrophils to sites of sterile inflammation, Science, vol.330, issue.6002, pp.362-366, 2010.

T. Kambayashi and T. M. Laufer, Atypical MHC class II-expressing antigenpresenting cells: can anything replace a dendritic cell?, Nat. Rev. Immunol, vol.14, issue.11, pp.719-730, 2014.
DOI : 10.1038/nri3754

N. D. Jones, M. O. Brook, M. Carvalho-gaspar, S. Luo, and K. J. Wood, Regulatory T cells can prevent memory CD8+ T-cell-mediated rejection following polymorphonuclear cell depletion, Eur. J. Immunol, vol.40, issue.11
DOI : 10.1002/eji.201040671

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.201040671

N. Sailliet, Cytokine and Growth Factor Reviews, vol.47, pp.3107-3116, 2010.

M. J. Bogman, I. M. Cornelissen, and R. A. Koene, Absence of requirement for polymorphonuclear granulocytes in the acute antibody-mediated rejection of murine skin allografts, Transplantation, vol.37, issue.4, pp.402-405, 1984.

E. Calama, I. Ramis, A. Dome`nech, C. Carrenõ, J. D. Alba et al., Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS, Pulm. Pharmacol. Ther, vol.43, pp.60-67, 2017.

R. Li and G. Wang, JAK/STAT5 Signaling Pathway Inhibitor Ruxolitinib Reduces Airway Inflammation of Neutrophilic Asthma in Mice Model, European Review, 2018.

A. Le-moine, V. Flamand, F. Demoor, J. Noel, M. Surquin et al., Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection, J. Clin. Invest, vol.103, issue.12, pp.1659-1667, 1999.

W. Hongwei, R. S. Nanra, A. Stein, L. Avis, A. Price et al., Eosinophils in acute renal allograft rejection, Transpl. Immunol, vol.2, issue.1, pp.41-46, 1994.

P. Cravedi, D. A. Lessman, and P. S. Heeger, Eosinophils are not required for the induction and maintenance of an alloantibody response: eosinophils in the alloantibody response, Am. J. Transplant, vol.13, issue.10, pp.2696-2702, 2013.

K. Ochiai, E. Tanabe, C. Ishihara, M. Kagami, T. Sugiyama et al., Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon-gamma (IFN-g), Clin. Exp. Immunol, vol.118, issue.3, pp.340-343, 1999.

G. Schiechl, F. J. Hermann, M. Gomez, S. Kutzi, K. Schmidbauer et al., Basophils trigger fibroblast activation in cardiac allograft fibrosis development, Am. J. Transplant, vol.16, issue.9, pp.2574-2588, 2016.

W. Schonfeld, A. Saak, and G. Steinkamp, Histamine release from basophils in cystic fibrosis, Clin. Exp. Immunol, vol.76, pp.434-439, 1989.

B. Strober, M. Buonanno, J. D. Clark, T. Kawabata, H. Tan et al., Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment, Br. J. Dermatol, vol.169, issue.5, pp.992-999, 2013.

D. K. Nayak, F. Zhou, M. Xu, J. Huang, M. Tsuji et al., Long-term persistence of donor alveolar macrophages in human lung transplant recipients that influences donor-specific immune responses, Am. J. Transplant, vol.16, issue.8, pp.2300-2311, 2016.

E. Ajda-tahereh-rowshani and . Vereyken, The role of macrophage lineage cells in kidney graft rejection and survival, Transplantation, vol.94, issue.4, p.309, 2012.

E. Vinuesa, G. Hotter, M. Jung, I. Herrero-fresneda, J. Torras et al., Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury, J. Pathol, vol.214, issue.1, pp.104-113, 2008.

Y. Wang, Y. P. Wang, G. Zheng, V. W. Lee, L. Ouyang et al., Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease, Kidney Int, vol.72, issue.3, pp.290-299, 2007.

J. A. Hutchinson, P. Riquelme, G. Beate, M. Brem-exner, M. Schulze et al., Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation, Transpl. Int, vol.21, issue.8, pp.728-741, 2008.

J. A. Hutchinson, P. Riquelme, B. Sawitzki, S. Tomiuk, P. Miqueu et al., Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients, J. Immunol, vol.187, issue.5, pp.2072-2078, 2011.

M. Febvre-james, V. Lecureur, Y. Augagneur, A. Mayati, and O. Fardel, Repression of interferon b-regulated cytokines by the JAK1/2 inhibitor ruxolitinib in inflammatory human macrophages, Int. Immunopharmacol, vol.54, pp.354-365, 2018.

Y. Liang, H. Tang, Z. Chen, L. Zeng, J. Wu et al., Downregulated SOCS1 expression activates the JAK1/ STAT1 pathway and promotes polarization of macrophages into M1 type, Mol. Med. Rep, vol.16, issue.5, pp.6405-6411, 2017.

Y. Yu, B. R. Blokhuis, J. Garssen, and F. A. Redegeld, Non-IgE mediated mast cell activation, Eur. J. Pharmacol, vol.778, pp.33-43, 2016.

C. J. Wingard, D. M. Walters, B. L. Cathey, S. C. Hilderbrand, P. Katwa et al., Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation, Nanotoxicology, vol.5, issue.4, pp.531-545, 2011.
DOI : 10.3109/17435390.2010.530004

URL : http://europepmc.org/articles/pmc3208763?pdf=render

M. Su, E. Y. Chi, M. J. Bishop, and W. R. Henderson, Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs, Am. Rev. Respir. Dis, vol.147, issue.2, pp.448-456, 1993.

A. W. Maud, B. Hermans, C. C. Schrijver, R. G. Van-holten-neelen, P. Wijk et al., The JAK1/JAK2-inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release, Clin. Exp. Allergy, vol.48, issue.11, 2018.

J. Janusz, W. Kulagowski, R. J. Blair, C. Bull, G. Chang et al., Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors, J. Med. Chem, vol.55, issue.12, pp.5901-5921, 2012.

M. Kim, H. Shin, K. Park, H. Kim, J. Park et al., Benzimidazole derivatives as potent JAK1-Selective inhibitors, J. Med. Chem, vol.58, issue.18, pp.7596-7602, 2015.
DOI : 10.1021/acs.jmedchem.5b01263

K. J. Weinhold, J. F. Bukowski, T. V. Brennan, R. J. Noveck, J. S. Staats et al., Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers, Clin. Immunol, vol.191, pp.10-20, 2018.

N. Sailliet, PhD student): started a thesis supervised by Sophie Brouard and Jean-Michel Robert on the development of new kinase inhibitors to specifically target JAK1

S. Brouard, (. Vmd, and P. , Since 2011, she is Director and Coordinator of the CENTAURE national RTRS network. She is co-author of 10 patents, 121 original articles, 42 reviews/books and importantly she discovered with her team IL7R as a potential, leads a team of 32 researchers at the ITUN

J. Robert, He leads researches based on the development of PI3K and JAK inhibitors and pro-apoptosis molecules for cancer therapy

C. Brosseau, PhD): joined Sophie Brouard's team to characterize B lymphocyte signature in chronic lung allograft dysfunction and to characterize CD9+ regulatory B cells induction of effector T cell apoptosis as a new therapeutic strategy for severe asthma

N. Sailliet, Cytokine and Growth Factor Reviews, vol.47, pp.62-73, 2019.